Literature DB >> 19720242

Characterization of the Varicella-zoster virus ORF25 gene product: pORF25 interacts with multiple DNA encapsidation proteins.

Robert J Visalli1, Jacquelyn Knepper, Bradley Goshorn, Katherine Vanover, Denise M Burnside, Karen Irven, Rebecca McGauley, Melissa Visalli.   

Abstract

The Herpesviridae contain a group of highly conserved proteins designated the Herpes UL33 Superfamily (pfam03581). The Varicella-zoster virus (VZV) homolog, encoded by the ORF25 gene, was used to generate a GST-ORF25 fusion protein. Purified GST-ORF25 was used to generate a polyclonal rabbit antiserum that detected the 17.5 kDa ORF25 protein (pORF25) in VZV infected cells. In pull-down assays, GST-ORF25 interacted with a number of encapsidation proteins including ORF30, ORF42 (the second exon of ORF45/42) and itself. The self-interaction was confirmed via a yeast two-hybrid assay. Additionally, pORF25 and pORF30 were shown to co-immunoprecipitate from VZV infected cells. Our results suggest that pORF25 is part of the trimeric terminase complex for VZV. However, combined with data from previous studies on HSV-1 and Kaposi's sarcoma associated herpesvirus (KSVH), we hypothesize that VZV pORF25 and the Herpes UL33 Superfamily homologs are not encapsidation proteins per se but instead work to bring viral proteins together to form functional complexes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19720242      PMCID: PMC2736913          DOI: 10.1016/j.virusres.2009.03.019

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  27 in total

1.  Characterization of the U(L)33 gene product of herpes simplex virus 1.

Authors:  A E Reynolds; Y Fan; J D Baines
Journal:  Virology       Date:  2000-01-20       Impact factor: 3.616

2.  ATPase activity of the terminase subunit pUL56 of human cytomegalovirus.

Authors:  Jae-Seon Hwang; Elke Bogner
Journal:  J Biol Chem       Date:  2001-12-13       Impact factor: 5.157

3.  DNA cleavage and packaging proteins encoded by genes U(L)28, U(L)15, and U(L)33 of herpes simplex virus type 1 form a complex in infected cells.

Authors:  Philippa M Beard; Naomi S Taus; Joel D Baines
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

4.  Identification of small molecule compounds that selectively inhibit varicella-zoster virus replication.

Authors:  Robert J Visalli; Jeanette Fairhurst; Shamala Srinivas; William Hu; Boris Feld; Martin DiGrandi; Kevin Curran; Adma Ross; Jonathan D Bloom; Marja van Zeijl; Thomas R Jones; John O'Connell; Jeffrey I Cohen
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

5.  The terminase subunits pUL56 and pUL89 of human cytomegalovirus are DNA-metabolizing proteins with toroidal structure.

Authors:  Hanno Scheffczik; Christos G W Savva; Andreas Holzenburg; Larissa Kolesnikova; Elke Bogner
Journal:  Nucleic Acids Res       Date:  2002-04-01       Impact factor: 16.971

6.  The UL14 protein of herpes simplex virus type 2 translocates the minor capsid protein VP26 and the DNA cleavage and packaging UL33 protein into the nucleus of coexpressing cells.

Authors:  Yohei Yamauchi; Kaoru Wada; Fumi Goshima; Hiroki Takakuwa; Tohru Daikoku; Masao Yamada; Yukihiro Nishiyama
Journal:  J Gen Virol       Date:  2001-02       Impact factor: 3.891

7.  Novel non-nucleoside inhibitors of cytomegaloviruses (BAY 38-4766): in vitro and in vivo antiviral activity and mechanism of action.

Authors:  J Reefschlaeger; W Bender; S Hallenberger; O Weber; P Eckenberg; S Goldmann; M Haerter; I Buerger; J Trappe; J A Herrington; D Haebich; H Ruebsamen-Waigmann
Journal:  J Antimicrob Chemother       Date:  2001-12       Impact factor: 5.790

8.  A novel nonnucleoside inhibitor specifically targets cytomegalovirus DNA maturation via the UL89 and UL56 gene products.

Authors:  I Buerger; J Reefschlaeger; W Bender; P Eckenberg; A Popp; O Weber; S Graeper; H D Klenk; H Ruebsamen-Waigmann; S Hallenberger
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

Review 9.  Human cytomegalovirus terminase as a target for antiviral chemotherapy.

Authors:  Elke Bogner
Journal:  Rev Med Virol       Date:  2002 Mar-Apr       Impact factor: 6.989

10.  Characterization of pseudorabies virus (PrV) cleavage-encapsidation proteins and functional complementation of PrV pUL32 by the homologous protein of herpes simplex virus type 1.

Authors:  Walter Fuchs; Barbara G Klupp; Harald Granzow; Tobias Leege; Thomas C Mettenleiter
Journal:  J Virol       Date:  2009-02-04       Impact factor: 5.103

View more
  8 in total

Review 1.  Herpesvirus Capsid Assembly and DNA Packaging.

Authors:  Jason D Heming; James F Conway; Fred L Homa
Journal:  Adv Anat Embryol Cell Biol       Date:  2017       Impact factor: 1.231

2.  Sensitivity of the C-Terminal Nuclease Domain of Kaposi's Sarcoma-Associated Herpesvirus ORF29 to Two Classes of Active-Site Ligands.

Authors:  Jennifer T Miller; Haiyan Zhao; Takashi Masaoka; Brittany Varnado; Elena M Cornejo Castro; Vickie A Marshall; Kaivon Kouhestani; Anna Y Lynn; Keith E Aron; Anqi Xia; John A Beutler; Danielle R Hirsch; Liang Tang; Denise Whitby; Ryan P Murelli; Stuart F J Le Grice
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

3.  Mutual Interplay between the Human Cytomegalovirus Terminase Subunits pUL51, pUL56, and pUL89 Promotes Terminase Complex Formation.

Authors:  Sebastian Neuber; Karen Wagner; Thomas Goldner; Peter Lischka; Lars Steinbrueck; Martin Messerle; Eva Maria Borst
Journal:  J Virol       Date:  2017-05-26       Impact factor: 5.103

4.  Intermolecular Complementation between Two Varicella-Zoster Virus pORF30 Terminase Domains Essential for DNA Encapsidation.

Authors:  Melissa A Visalli; Brittany L House; Frances J Lahrman; Robert J Visalli
Journal:  J Virol       Date:  2015-07-22       Impact factor: 5.103

5.  The varicella-zoster virus portal protein is essential for cleavage and packaging of viral DNA.

Authors:  Melissa A Visalli; Brittany L House; Anca Selariu; Hua Zhu; Robert J Visalli
Journal:  J Virol       Date:  2014-05-07       Impact factor: 5.103

6.  Epstein-Barr virus BALF3 has nuclease activity and mediates mature virion production during the lytic cycle.

Authors:  Shih-Hsin Chiu; Meng-Chuan Wu; Chung-Chun Wu; Yu-Ching Chen; Su-Fang Lin; John T-A Hsu; Chung-Shi Yang; Ching-Hwa Tsai; Kenzo Takada; Mei-Ru Chen; Jen-Yang Chen
Journal:  J Virol       Date:  2014-02-19       Impact factor: 5.103

7.  Varicella zoster virus ORF25 gene product: an essential hub protein linking encapsidation proteins and the nuclear egress complex.

Authors:  Maria G Vizoso Pinto; Venkata R Pothineni; Rudolf Haase; Mathias Woidy; Amelie S Lotz-Havla; Søren W Gersting; Ania C Muntau; Jürgen Haas; Marvin Sommer; Ann M Arvin; Armin Baiker
Journal:  J Proteome Res       Date:  2011-10-26       Impact factor: 4.466

8.  Changes in subcellular localization reveal interactions between human cytomegalovirus terminase subunits.

Authors:  Jian Ben Wang; Yali Zhu; Michael A McVoy; Deborah S Parris
Journal:  Virol J       Date:  2012-12-21       Impact factor: 4.099

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.